Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria.
The global Vaccine for Non-infectious Meningitis market is valued at 1 million US$ in 2018 and will reach 2 million US$ by the end of 2025, growing at a CAGR of 12.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vaccine for Non-infectious Meningitis market based on company, product type, end user and key regions.
This report studies the global market size of Vaccine for Non-infectious Meningitis in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vaccine for Non-infectious Meningitis in these regions.
This research report categorizes the global Vaccine for Non-infectious Meningitis market by top players/brands, region, type and end user. This report also studies the global Vaccine for Non-infectious Meningitis market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Serum Institute (India)
Sanofi SA (France)
Pfizer (USA)
Nuron Biotech (USA)
JN-International Medical (USA)
Market size by Product
Polysaccharide Vaccines
Conjugate Vaccines
Combination Vaccines
Men B Vaccines
Market size by End User
Meningitis
Septicemia
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Vaccine for Non-infectious Meningitis market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Vaccine for Non-infectious Meningitis market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Vaccine for Non-infectious Meningitis companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Vaccine for Non-infectious Meningitis submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Vaccine for Non-infectious Meningitis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vaccine for Non-infectious Meningitis market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
1.1 Vaccine for Non-infectious Meningitis Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Vaccine for Non-infectious Meningitis Market Size Growth Rate by Product
1.4.2 Polysaccharide Vaccines
1.4.3 Conjugate Vaccines
1.4.4 Combination Vaccines
1.4.5 Men B Vaccines
1.5 Market by End User
1.5.1 Global Vaccine for Non-infectious Meningitis Market Size Growth Rate by End User
1.5.2 Meningitis
1.5.3 Septicemia
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Vaccine for Non-infectious Meningitis Market Size
2.1.1 Global Vaccine for Non-infectious Meningitis Revenue 2014-2025
2.1.2 Global Vaccine for Non-infectious Meningitis Sales 2014-2025
2.2 Vaccine for Non-infectious Meningitis Growth Rate by Regions
2.2.1 Global Vaccine for Non-infectious Meningitis Sales by Regions
2.2.2 Global Vaccine for Non-infectious Meningitis Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Vaccine for Non-infectious Meningitis Sales by Manufacturers
3.1.1 Vaccine for Non-infectious Meningitis Sales by Manufacturers
3.1.2 Vaccine for Non-infectious Meningitis Sales Market Share by Manufacturers
3.1.3 Global Vaccine for Non-infectious Meningitis Market Concentration Ratio (CR5 and HHI)
3.2 Vaccine for Non-infectious Meningitis Revenue by Manufacturers
3.2.1 Vaccine for Non-infectious Meningitis Revenue by Manufacturers (2014-2019)
3.2.2 Vaccine for Non-infectious Meningitis Revenue Share by Manufacturers (2014-2019)
3.3 Vaccine for Non-infectious Meningitis Price by Manufacturers
3.4 Vaccine for Non-infectious Meningitis Manufacturing Base Distribution, Product Types
3.4.1 Vaccine for Non-infectious Meningitis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Vaccine for Non-infectious Meningitis Product Type
3.4.3 Date of International Manufacturers Enter into Vaccine for Non-infectious Meningitis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Vaccine for Non-infectious Meningitis Sales by Product
4.2 Global Vaccine for Non-infectious Meningitis Revenue by Product
4.3 Vaccine for Non-infectious Meningitis Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Vaccine for Non-infectious Meningitis Breakdown Data by End User
6 North America
6.1 North America Vaccine for Non-infectious Meningitis by Countries
6.1.1 North America Vaccine for Non-infectious Meningitis Sales by Countries
6.1.2 North America Vaccine for Non-infectious Meningitis Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Vaccine for Non-infectious Meningitis by Product
6.3 North America Vaccine for Non-infectious Meningitis by End User
7 Europe
7.1 Europe Vaccine for Non-infectious Meningitis by Countries
7.1.1 Europe Vaccine for Non-infectious Meningitis Sales by Countries
7.1.2 Europe Vaccine for Non-infectious Meningitis Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Vaccine for Non-infectious Meningitis by Product
7.3 Europe Vaccine for Non-infectious Meningitis by End User
8 Asia Pacific
8.1 Asia Pacific Vaccine for Non-infectious Meningitis by Countries
8.1.1 Asia Pacific Vaccine for Non-infectious Meningitis Sales by Countries
8.1.2 Asia Pacific Vaccine for Non-infectious Meningitis Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Vaccine for Non-infectious Meningitis by Product
8.3 Asia Pacific Vaccine for Non-infectious Meningitis by End User
9 Central & South America
9.1 Central & South America Vaccine for Non-infectious Meningitis by Countries
9.1.1 Central & South America Vaccine for Non-infectious Meningitis Sales by Countries
9.1.2 Central & South America Vaccine for Non-infectious Meningitis Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Vaccine for Non-infectious Meningitis by Product
9.3 Central & South America Vaccine for Non-infectious Meningitis by End User
10 Middle East and Africa
10.1 Middle East and Africa Vaccine for Non-infectious Meningitis by Countries
10.1.1 Middle East and Africa Vaccine for Non-infectious Meningitis Sales by Countries
10.1.2 Middle East and Africa Vaccine for Non-infectious Meningitis Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Vaccine for Non-infectious Meningitis by Product
10.3 Middle East and Africa Vaccine for Non-infectious Meningitis by End User
11 Company Profiles
11.1 Serum Institute (India)
11.1.1 Serum Institute (India) Company Details
11.1.2 Company Business Overview
11.1.3 Serum Institute (India) Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Serum Institute (India) Vaccine for Non-infectious Meningitis Products Offered
11.1.5 Serum Institute (India) Recent Development
11.2 Sanofi SA (France)
11.2.1 Sanofi SA (France) Company Details
11.2.2 Company Business Overview
11.2.3 Sanofi SA (France) Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Sanofi SA (France) Vaccine for Non-infectious Meningitis Products Offered
11.2.5 Sanofi SA (France) Recent Development
11.3 Pfizer (USA)
11.3.1 Pfizer (USA) Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer (USA) Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Pfizer (USA) Vaccine for Non-infectious Meningitis Products Offered
11.3.5 Pfizer (USA) Recent Development
11.4 Nuron Biotech (USA)
11.4.1 Nuron Biotech (USA) Company Details
11.4.2 Company Business Overview
11.4.3 Nuron Biotech (USA) Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Nuron Biotech (USA) Vaccine for Non-infectious Meningitis Products Offered
11.4.5 Nuron Biotech (USA) Recent Development
11.5 JN-International Medical (USA)
11.5.1 JN-International Medical (USA) Company Details
11.5.2 Company Business Overview
11.5.3 JN-International Medical (USA) Vaccine for Non-infectious Meningitis Sales, Revenue and Gross Margin (2014-2019)
11.5.4 JN-International Medical (USA) Vaccine for Non-infectious Meningitis Products Offered
11.5.5 JN-International Medical (USA) Recent Development
12 Future Forecast
12.1 Vaccine for Non-infectious Meningitis Market Forecast by Regions
12.1.1 Global Vaccine for Non-infectious Meningitis Sales Forecast by Regions 2019-2025
12.1.2 Global Vaccine for Non-infectious Meningitis Revenue Forecast by Regions 2019-2025
12.2 Vaccine for Non-infectious Meningitis Market Forecast by Product
12.2.1 Global Vaccine for Non-infectious Meningitis Sales Forecast by Product 2019-2025
12.2.2 Global Vaccine for Non-infectious Meningitis Revenue Forecast by Product 2019-2025
12.3 Vaccine for Non-infectious Meningitis Market Forecast by End User
12.4 North America Vaccine for Non-infectious Meningitis Forecast
12.5 Europe Vaccine for Non-infectious Meningitis Forecast
12.6 Asia Pacific Vaccine for Non-infectious Meningitis
List of Tables and Figures
Figure Vaccine for Non-infectious Meningitis Product Picture
Table Vaccine for Non-infectious Meningitis Market Segments
Table Key Manufacturers Vaccine for Non-infectious Meningitis Covered
Table Global Vaccine for Non-infectious Meningitis Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Vaccine for Non-infectious Meningitis Sales Market Share by Product 2014-2025
Figure Polysaccharide Vaccines Product Picture
Table Major Manufacturers of Polysaccharide Vaccines
Figure Conjugate Vaccines Product Picture
Table Major Manufacturers of Conjugate Vaccines
Figure Combination Vaccines Product Picture
Table Major Manufacturers of Combination Vaccines
Figure Men B Vaccines Product Picture
Table Major Manufacturers of Men B Vaccines
Table Global Vaccine for Non-infectious Meningitis Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Meningitis
Figure Septicemia
Figure Others
Figure Vaccine for Non-infectious Meningitis Report Years Considered
Figure Global Vaccine for Non-infectious Meningitis Market Size 2014-2025 (Million US$)
Figure Global Vaccine for Non-infectious Meningitis Sales 2014-2025 (K Units)
Table Global Vaccine for Non-infectious Meningitis Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Vaccine for Non-infectious Meningitis Sales by Regions 2014-2019 (K Units)
Table Global Vaccine for Non-infectious Meningitis Sales Market Share by Regions 2014-2019
Figure Global Vaccine for Non-infectious Meningitis Sales Market Share by Regions 2014-2019
Figure 2018 Global Vaccine for Non-infectious Meningitis Sales Market Share by Regions
Table Global Vaccine for Non-infectious Meningitis Revenue by Regions 2014-2019 (Million US$)
Table Global Vaccine for Non-infectious Meningitis Revenue Market Share by Regions 2014-2019
Figure Global Vaccine for Non-infectious Meningitis Revenue Market Share by Regions 2014-2019
Figure 2018 Global Vaccine for Non-infectious Meningitis Revenue Market Share by Regions
Table Global Vaccine for Non-infectious Meningitis Sales by Manufacturers (2014-2019) (K Units)
Table Global Vaccine for Non-infectious Meningitis Sales Share by Manufacturers (2014-2019)
Figure Global Vaccine for Non-infectious Meningitis Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Vaccine for Non-infectious Meningitis Revenue by Manufacturers (2014-2019) (Million USD)
Table Vaccine for Non-infectious Meningitis Revenue Share by Manufacturers (2014-2019)
Figure Vaccine for Non-infectious Meningitis Value Share by Manufacturers in 2018
Table Key Manufacturers Vaccine for Non-infectious Meningitis Price (2014-2019) (USD/Unit)
Table Vaccine for Non-infectious Meningitis Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Vaccine for Non-infectious Meningitis Product Type
Table Date of International Manufacturers Enter into Vaccine for Non-infectious Meningitis Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Vaccine for Non-infectious Meningitis Sales by Product (2014-2019) (K Units)
Table Global Vaccine for Non-infectious Meningitis Sales Share by Product (2014-2019)
Figure Global Vaccine for Non-infectious Meningitis Sales Market Share by Product (2014-2019)
Figure Global Vaccine for Non-infectious Meningitis Sales Market Share by Product in 2018
Table Global Vaccine for Non-infectious Meningitis Revenue by Product (2014-2019) (Million US$)
Table Global Vaccine for Non-infectious Meningitis Revenue Share by Product (2014-2019)
Figure Global Vaccine for Non-infectious Meningitis Revenue Market Share by Product (2014-2019)
Figure Global Vaccine for Non-infectious Meningitis Revenue Market Share by Product in 2018
Table Vaccine for Non-infectious Meningitis Price by Product 2014-2019 (USD/Unit)
Table Global Vaccine for Non-infectious Meningitis Sales by End User (2014-2019) (K Units)
Table Global Vaccine for Non-infectious Meningitis Sales Share by End User (2014-2019)
Figure Global Sales Vaccine for Non-infectious Meningitis Market Share by End User (2014-2019)
Figure Global Sales Vaccine for Non-infectious Meningitis Market Share by End User in 2018
Figure North America Vaccine for Non-infectious Meningitis Sales Growth Rate 2014-2019 (K Units)
Figure North America Vaccine for Non-infectious Meningitis Revenue Growth Rate 2014-2019 (Million US$)
Table North America Vaccine for Non-infectious Meningitis Sales by Countries (2014-2019) (K Units)
Table North America Vaccine for Non-infectious Meningitis Sales Market Share by Countries (2014-2019)
Figure 2018 North America Vaccine for Non-infectious Meningitis Sales Market Share by Countries
Table North America Vaccine for Non-infectious Meningitis Revenue by Countries (2014-2019) (Million US$)
Table North America Vaccine for Non-infectious Meningitis Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Vaccine for Non-infectious Meningitis Revenue Market Share by Countries
Figure United States Vaccine for Non-infectious Meningitis Sales Growth Rate (2014-2019) (K Units)
Figure United States Vaccine for Non-infectious Meningitis Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Vaccine for Non-infectious Meningitis Sales Growth Rate (2014-2019) (K Units)
Figure Canada Vaccine for Non-infectious Meningitis Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Vaccine for Non-infectious Meningitis Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Vaccine for Non-infectious Meningitis Revenue Growth Rate (2014-2019) (Million US$)
Table North America Vaccine for Non-infectious Meningitis Sales by Product (2014-2019) (K Units)
Table North America Vaccine for Non-infectious Meningitis Sales Market Share by Product (2014-2019)
Figure 2018 North America Vaccine for Non-infectious Meningitis Market Share by Product
Table North America Vaccine for Non-infectious Meningitis Sales by End User (2014-2019) (K Units)
Table North America Vaccine for Non-infectious Meningitis Sales Market Share by End User (2014-2019)
Figure 2018 North America Vaccine for Non-infectious Meningitis Market Share by End User
Figure Europe Vaccine for Non-infectious Meningitis Sales Growth Rate 2014-2019 (K Units)
Figure Europe Vaccine for Non-infectious Meningitis Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Vaccine for Non-infectious Meningitis Sales by Countries (2014-2019) (K Units)
Table Europe Vaccine for Non-infectious Meningitis Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Vaccine for Non-infectious Meningitis Sales Market Share by Countries
Table Europe Vaccine for Non-infectious Meningitis Revenue by Countries (2014-2019) (Million US$)
Table Europe Vaccine for Non-infectious Meningitis Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Vaccine for Non-infectious Meningitis Revenue Market Share by Countries
Figure Germany Vaccine for Non-infectious Meningitis Sales Growth Rate (2014-2019) (K Units)
Figure Germany Vaccine for Non-infectious Meningitis Revenue Growth Rate (2014-2019) (Million US$)
Figure France Vaccine for Non-infectious Meningitis Sales Growth Rate (2014-2019) (K Units)
Figure France Vaccine for Non-infectious Meningitis Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Vaccine for Non-infectious Meningitis Sales Growth Rate (2014-2019) (K Units)
Figure UK Vaccine for Non-infectious Meningitis Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Vaccine for Non-infectious Meningitis Sales Growth Rate (2014-2019) (K Units)
Figure Italy Vaccine for Non-infectious Meningitis Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Vaccine for Non-infect
$3900
$5850
$7800
Add to Cart
Add to Cart
Add to Cart
Add to Cart